The global molecular weight marker market was valued at $265.36 million in 2014 and is poised to grow at a CAGR of 12.23 % between 2014 and 2019, to reach $472.47 million in 2019.
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=117734545
Increased research and development spending by biotechnology and pharmaceutical companies, increasing public funding for life science research, and new innovations in genomics and proteomics research will drive the growth of the this market.
This report segments the global market by products, applications, and end users. The product segments included in the report are DNA, Protein and RNA markers. The DNA markers segment is subsegmented on the basis of marker sizes. The DNA markers size subsegments included in the report are below 50 base pair (bp), 50 bp to 100 bp, 100 bp to 1 kilo base pair (kb), 1 kb to 5 kb and above 5 kb. The protein markers segment is also subsegmented on the basis of marker sizes. The protein markers size subsegments included in the report are below 10 kilo Dalton (kDa), 10 kDa to 100 kDa, 100 kDa to 200 kDa and above 200 kDa markers. The report also includes a segmentation of the molecular weight markers on the basis of staining type. The type segments included in the report are prestained, unstained, and specialty markers.
The application segments included in this report are nucleic acid applications and protein applications. The nucleic acid applications segment is subsegmented into PCR, sequencing, northern blotting, southern blotting, molecular cloning, and other nucleic acid applications. The protein applications segment is subsegmented into western blotting, gel extraction, other protein applications. On the basis of end users the global molecular weight marker market report is segmented into academic research institutes, biotechnology and pharmaceutical companies, contract research organizations and other end users.
The report also includes a geographic analysis of this market. The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global market in 2014. Asia regional segment, on the other hand, is expected to register a faster growth from 2014 to 2019, due to the increasing in R&D for proteomics and genomics research from this region.
The major players of this market include F Hoffmann-La Roche AG (Switzerland),Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies (U.S.), Sigma-Aldrich (U.S.), Affymetrix, Inc.(U.S.), QIAGEN (Netherlands), Takara Bio Inc. (Japan), Bio-Rad Laboratories (U.S.), Promega Corporation (U.S.) and New England Biolabs (U.S.)
